Half Beta-Prograne

Half Beta-Prograne is a prescription oral medication containing propranolol hydrochloride as its active ingredient. It is supplied in tablet form (strength not specified) and is marketed in the European Union. Propranolol is a non‑selective beta‑adrenergic blocker used to manage several cardiovascular and neurological conditions. The product is classified as a beta blocker and requires a physician’s prescription. It is indicated for hypertension, angina, arrhythmias, migraine prophylaxis, and essential tremor.

Half Beta‑Prograne is prescribed for several cardiovascular and neurological indications where beta‑adrenergic blockade is beneficial.

- Hypertension (high blood pressure) - Angina pectoris (chest pain due to coronary artery disease) - Cardiac arrhythmias (including supraventricular and ventricular types) - Migraine prophylaxis (prevention of migraine attacks) - Essential tremor (tremor control) - Adjunct therapy for hyperthyroidism symptoms

Side effects of propranolol may vary in frequency and severity; patients should be aware of both common and serious reactions.

Common: - Fatigue or tiredness - Dizziness or light‑headedness - Cold hands and feet - Nausea, abdominal discomfort or diarrhea - Sleep disturbances or vivid dreams - Mild depressive mood

Serious: - Marked bradycardia (slow heart rate) - Significant hypotension (low blood pressure) - Heart block or worsening arrhythmias - Bronchospasm or severe asthma exacerbation - Severe depression, suicidal thoughts, or psychosis - Hypoglycemia, especially in patients with diabetes

Before starting Half Beta‑Prograne, clinicians should evaluate several precautionary factors to ensure safe use.

- Assess baseline cardiac function, heart rate, and blood pressure - Avoid use in patients with severe asthma, chronic obstructive pulmonary disease, or active bronchospasm - Monitor blood glucose closely in diabetic patients, as propranolol may mask hypoglycemia symptoms - Use caution in individuals with peripheral vascular disease or Raynaud’s phenomenon - Adjust dose in patients with hepatic or renal impairment - Review all concomitant medications that affect heart rate or blood pressure - Prescribe only when the potential benefit outweighs risk in pregnant or breastfeeding women

Propranolol can interact with a range of medicines; some combinations should be avoided while others require careful monitoring.

Avoid: - Other non‑selective beta blockers - Calcium‑channel blockers such as verapamil or diltiazem that may cause excessive bradycardia - Abrupt discontinuation of clonidine - Monoamine oxidase inhibitors (MAOIs) - Certain anti‑arrhythmic agents (e.g., amiodarone)

Use with caution: - Other antihypertensives (ACE inhibitors, diuretics, other beta blockers) - Antidiabetic agents (insulin, sulfonylureas) due to hypoglycemia risk - Antidepressants (SSRIs, tricyclics) that may affect cardiac conduction - Non‑steroidal anti‑inflammatory drugs (NSAIDs) which can blunt antihypertensive effect - Thyroid hormone replacement therapy